News
Phathom Pharmaceuticals, Inc. has secured 10 years of FDA exclusivity for Voquezna in GERD, boosting its stock. Click here to ...
Our Bureau, Mumbai Saturday, June 14, 2025, 13:30 Hrs [IST] ...
18hon MSN
Shanghvi’s son Aalok Shanghvi will take charge of the North America business, with new CEO Richard Ascroft reporting to him ...
No-moat Takeda Pharmaceutical is Japan’s leading pharmaceutical company by revenue. While the firm historically focused on the Japan market, management has undertaken an ambitious overhaul to ...
Takeda Pharmaceutical Company Limited (NYSE: TAK )’s ADCETRIS® (brentuximab vedotin) in combination with ECADD was authorized ...
Japanese borrowers have already sold more corporate bonds than they have for any June in four years, and the month isn’t even ...
Sun Pharma appoints Kirti Ganorkar as Managing Director, signaling succession planning and change in leadership.
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers ...
A team at Kobe University has created a game-changing resource for autism research: 63 mouse embryonic stem cell lines, each carrying a genetic mutation strongly associated with the disorder. By ...
Takeda Pharmaceutical Company Limited (NYSE:TAK) has announced the convocation of its 149th Ordinary General Meeting of Shareholders, set to take place in Tokyo, Japan. The notice, filed with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results